Group 1 - The major shareholder of Guofa Co., Ltd. (国发股份) has had a portion of shares frozen by the Nanning Qingxiu District People's Court, affecting approximately 39.69 million shares held by Zhu Rongjuan, 3.47 million shares held by Peng Tao, and 690,000 shares held by Guangxi Guofa Investment Group [1] - As of the announcement date, Guofa Co., Ltd. has a market capitalization of 3.1 billion yuan [2] - For the first half of 2025, the revenue composition of Guofa Co., Ltd. is as follows: pharmaceutical distribution accounts for 62.04%, DNA consumables and testing services account for 22.16%, pharmaceutical manufacturing accounts for 8.29%, judicial identification accounts for 6.22%, and other businesses account for 1.04% [1]

Group 1 - The major shareholder Zhu Rongjuan and her associate Peng Tao of Guofang Co., Ltd. are facing a financial dispute with Guangxi Beibu Gulf Bank, leading to the freezing of approximately 38.56 million and 3.37 million shares respectively as of November 5, 2025 [1] - As of the announcement date, Zhu Rongjuan has a total of about 39.69 million shares frozen, while Peng Tao has around 3.47 million shares frozen, and Guangxi Guofang Investment Group has about 180,000 shares frozen [1] - The company's market capitalization is currently valued at 3 billion yuan [1] Group 2 - For the first half of 2025, Guofang Co., Ltd.'s revenue composition is as follows: pharmaceutical distribution accounts for 62.04%, DNA consumables and testing services 22.16%, pharmaceutical manufacturing 8.29%, judicial identification 6.22%, and other businesses 1.04% [1]